April 20, 2026
| Trial | IDeate- Esophageal01 |
|---|---|
| Cancer Type | Oesophageal Cancer |
| Hospital(s) | Altnagelvin Hospital |
| Information | A Phase 3, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd) in Subjects with |
| Trial Open | Yes |
 |
Click Here to view trial summary |